Real-time enrollment status for this cystic fibrosis clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 11:28 PM UTC
| NCT Number | NCT05422222 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Cystic Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 210 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | May 28, 2026 (4 days ago) |
As of June 1, 2026: Clinical trial NCT05422222 is currently active_not_recruiting participants. This clinical trial study for cystic fibrosis is not currently accepting new participants at 19 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05422222 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05422222 was last updated 4 days ago (May 28, 2026). HelloStudys verifies this status automatically.